Women's Health Devicemaker CerviLenz Inc. Ups Series A to $8.35 Million
Published: Oct 21, 2011
Women’s health medical device company Cervilenz has increased its series A round of investment to $8.35 million, thanks to a recent tranche of funding from existing investors. Cleveland-area Cervilenz plans to use the funding to continue commercialization of its device, which provides a means of accurately and inexpensively measuring a pregnant woman’s cervix. A short cervix is the best predictor of preterm birth risk. “We’re focused on early adoption of the device and introducing it to the market,” said CEO Dean Koch, who was hesitant to reveal much about the company’s commercialization strategy for competitive reasons.